Cell and gene therapy jobs: science, engineering and data roles
390 open roles at 56 cell and gene therapy companies in 13 countries: Clinical, regulatory and drug development (130), Process and manufacturing engineering (70), Research science (61), Product, operations and leadership (54). 387 of them are open to candidates of any nationality; the rest ask for citizenship or a government security check. 18 mention relocation support.
agcbio.com · HQ: Bothell, United States · CRO & CDMO Services · Cell & Gene Therapy · 1001-5000 employees · Est. 2018 · Hiring 26, 6 new
HQ: Bothell, United States · CRO & CDMO Services · Cell & Gene Therapy · 1001-5000 employees · Est. 2018 · Hiring 26, 6 new
AGC Biologics is a global contract development and manufacturing organisation (CDMO) headquartered in Bothell, near Seattle, producing protein biologics, plasmid DNA, mRNA, viral vectors and genetically engineered cells for pharmaceutical and biotech clients. It was formed in January 2018 by combining the bioscience units of Japan's AGC (Asahi Glass) with Biomeva and CMC Biologics, and it runs facilities in Seattle, Copenhagen, Heidelberg, Milan and Chiba. It hires GMP manufacturing technicians, downstream and process development scientists, quality control and QA staff, EHS managers, material planners and student assistants.
alnylam.com · HQ: Cambridge, United States · Cardiometabolic Therapeutics · Rare Disease Therapeutics · Cell & Gene Therapy · 51-200 employees · Est. 2002 · Trust A · Hiring 91, 7 new
HQ: Cambridge, United States · Cardiometabolic Therapeutics · Rare Disease Therapeutics · Cell & Gene Therapy · 51-200 employees · Est. 2002 · Trust A · Hiring 91, 7 new
Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, that develops and commercialises RNA interference therapeutics for rare and common diseases, including ATTR amyloidosis and acute hepatic porphyria. Founded in Cambridge in 2002 and listed on the Nasdaq, it has six approved medicines available in more than 70 countries, a manufacturing site in Norton, Massachusetts, a European base in Maidenhead and an affiliate in Tokyo. It hires research and biology scientists, quality control analysts, clinical science and regulatory affairs staff, field reimbursement and key account managers, and IT, cyber defense and HR technology leaders.
ccrm.ca · Toronto · Hamilton · Cell & Gene Therapy · Regenerative Medicine · Est. 2011 · Hiring 9, 1 new
Toronto · Hamilton · Cell & Gene Therapy · Regenerative Medicine · Est. 2011 · Hiring 9, 1 new
CCRM brings together stakeholders, expertise, infrastructure and funding to accelerate the development and commercialization of regenerative medicines.
exthymic.com · HQ: San Diego, United States · Regenerative Medicine · Cell & Gene Therapy · 51-200 employees · Est. 2023 · Startup · Hiring 3, 1 new
HQ: San Diego, United States · Regenerative Medicine · Cell & Gene Therapy · 51-200 employees · Est. 2023 · Startup · Hiring 3, 1 new
Exthymic is an early-stage deep-tech startup that develops point-of-care manufacturing systems for patient-specific cell therapies. Its platform combines hardware, software and biological engineering to make curative cell therapies for cancer widely accessible. The company is headquartered in San Diego, California, United States.
kitepharma.com · HQ: Santa Monica, United States · Oncology Therapeutics · Cell & Gene Therapy · 1001-5000 employees · Est. 2009 · Hiring 50, 9 new
HQ: Santa Monica, United States · Oncology Therapeutics · Cell & Gene Therapy · 1001-5000 employees · Est. 2009 · Hiring 50, 9 new
Kite Pharma is a biopharmaceutical company headquartered in Santa Monica, California, that develops and manufactures personalised CAR T-cell therapies for blood cancers and runs research on next-generation cell therapies. Founded in 2009 and acquired by Gilead Sciences in 2017, it operates as an independent Gilead company with manufacturing in El Segundo, Frederick, Maryland, and Hoofddorp in the Netherlands, and plans to move Santa Monica staff to El Segundo and Thousand Oaks from 2027. It hires process development, quality and IT quality engineers, clinical data managers, regulatory and pharmacovigilance managers, sales analytics staff and field cell therapy directors.
4dmoleculartherapeutics.com · HQ: Emeryville, United States · Cell & Gene Therapy · 201-500 employees · Est. 2015 · NASDAQ: FDMT · Hiring 14, 4 new
HQ: Emeryville, United States · Cell & Gene Therapy · 201-500 employees · Est. 2015 · NASDAQ: FDMT · Hiring 14, 4 new
4D Molecular Therapeutics is a clinical-stage American biotechnology company that develops gene therapies. It uses its Therapeutic Vector Evolution platform to engineer adeno-associated virus vectors, and its pipeline targets eye diseases such as wet age-related macular degeneration as well as lung and cardiac conditions. Founded in 2015, the company is headquartered in Emeryville, California, United States, and is listed on Nasdaq.
Companies whose main business is biotechnology, drug discovery and development, cell and gene therapy, genomics, contract research and manufacturing (CRO, CDMO) or life science tools - and every role whose title names biotech work at any employer. Their sales, finance and office roles are left out: these pages list the science, engineering, data and IT roles.
How fresh is this?
Every role is re-checked on the employer's own careers board at least every 48 hours, and the page is rebuilt every night.
Alnylam
Legend Biotech
Orca Bio
Kite Pharma
AGC Biologics
NewLimit
ElevateBio
Mytos
Profluent
crisprtx
Altos Labs
Beam Therapeutics
uniQure
Aspectbiosystems
Allogene Therapeutics
